Centuries of exploration.
Audiences for The Heart witness an extraordinary race against time. In 90 minutes of theatrical storytelling, the musical follows the 24-hour journey of a single heart transplant. The show’s urgency reminds us that every minute matters, but the ability to transplant organs took more than a century to achieve. The vision of replacing diseased body parts in humans reaches beyond modern medicine: ancient Greek, Roman, and Chinese myths tell stories of miraculous transplants performed by gods or legendary healers. Around 800 BCE, physicians in India were likely performing grafts on skin—technically the body’s largest organ—to repair wounds and burns.
Modern medicine had to overcome three major challenges before an organ could be surgically transplanted from one human being to another:
- How to reconnect delicate blood vessels so a transplanted organ could function
- How to prevent the body’s immune system from rejecting that organ
- How to preserve donor organs long enough to transport them safely across locations
Only after all three problems were addressed did transplantation become a safe and reliable medical intervention. After these successes, a host of ethical questions arose around who is chosen to receive an organ and how such decisions are made.

A surgical foundation.
In the early 20th century, French surgeon Alexis Carrel developed surgical techniques allowing blood vessels to be joined with extraordinary precision. Working with American physiologist Charles Guthrie, Carrel’s animal experiments demonstrated that circulation could be restored to transplanted tissues and organs. Their work centered on vascular anastomosis—the careful joining of arteries and veins—which remains fundamental to transplantation today. Carrel used exceptionally fine needles and sutures, while maintaining meticulous sterile technique at a time when infection remained a major obstacle to surgery. Carrel received the 1912 Nobel Prize for his advances. However, as surgical techniques improved, the next major challenge emerged: a transplanted organ might be connected perfectly and receive a healthy blood supply—but still fail.
A major understanding emerged in 1943, when Oxford zoologist Peter Medawar and plastic surgeon Thomas Gibson realized that organ rejection is an immune response rather than a surgical failure. The immune system is designed to recognize and destroy foreign material—including transplanted organs. Stopping this process required a new field of research.
Further exploration and the challenge of rejection.
In their ongoing quest to suppress the immune system, physicians in the ‘50s and ‘60s experimented with radiation treatments, bone marrow transplantation, and medications designed to suppress the immune system. Meanwhile, some surgical advances pointed the way forward.
In 1954, surgeon Joseph Murray performed the world’s first successful human kidney transplant between identical twin brothers at Boston’s Peter Bent Brigham Hospital. Because the twins were genetically identical, the recipient’s immune system recognized the kidney as its own. No anti-rejection medication was necessary, and the recipient lived another eight years. The operation proved that organ transplantation could save lives, inspiring surgeons around the world to pursue transplantation with renewed determination. Murray ultimately received the Nobel Prize in Physiology or Medicine in 1990.
Success with kidney transplantation inspired experiments with other organs. In 1967, Thomas Starzl performed the first human liver transplant, while continuing to refine surgical techniques and early immunosuppressive therapies. Survival rates remained low, but each operation expanded physicians’ understanding of what was possible.
Also in 1967, transplantation entered the global spotlight when South African surgeon Christiaan Barnard performed the world’s first human-to-human heart transplant. His patient survived only 18 days, ultimately dying from pneumonia and infection, but his next heart transplant, performed only days later, allowed a patient to survive for 18 months. Barnard’s operations demonstrated that transplanting a human heart was technically possible and galvanized transplant research around the world.
Researchers Joseph Murray and Roy Caine made a huge step towards solving organ rejection with the chemical suppressive agent azathioprine, which permitted the first successful kidney transplant between unrelated individuals (also from a deceased donor) in 1962. The next breakthrough arrived in the 1970s with the discovery of cyclosporine, which unlike earlier agents, specifically targeted T cells—key players in the immune response responsible for organ rejection. Clinical trials demonstrated dramatically improved survival, and after FDA approval in 1983, heart transplant survival increased from less than 50% to more than 80% after one year.
Today, newer medications such as tacrolimus have become the standard foundation of anti-rejection therapy. Meanwhile, physicians have developed increasingly sophisticated ways to monitor transplanted organs. Heart biopsies, gene-expression profiling, and molecular diagnostic techniques now allow doctors to detect signs of rejection earlier and treat patients more precisely than ever before.
Solving organ preservation.
Next came the challenge of how quickly deterioration begins after an organ is removed from the body, and how to preserve it while it travels to the recipient. As early as 1905, Guthrie proposed cooling organs to slow deterioration. By the ‘60s, surgeons routinely flushed donor kidneys and livers with cold preservation solutions before transplantation. Machine perfusion systems that pump preservation fluids through donor organs could extend their viability even further. The “University of Wisconsin solution” was found in 1987 to preserve donor organs for two to three days, simply by being injected into an organ’s blood vessels without the need for a pump. This became a standard preservation technique.
Even with these developments, doctors today are in a race with time. Kidneys must be transplanted within about 36 hours after recovery. Livers, pancreases, and intestines have about 12 hours, while hearts and lungs have the shortest window—typically no more than 6 hours. New technologies, including the Organ Care System (OCS™), keep organs warm, oxygenated, and functioning during transport, potentially increasing both preservation time and the quantity of organs available for transplantation.
Supply, demand, and ethical distribution.
Advances in transplantation lead to new questions, including how do we determine when death occurs? Medically, death has long been defined by the permanent cessation of heartbeat and breathing. However, organs begin to deteriorate rapidly once blood circulation stops. Physicians understood the benefit of removing organs while the heart was still beating but the brain had stopped functioning. In 1968, the Harvard Ad Hoc Committee on Brain Death formally recommended that an irreversible coma (such as Simon’s condition in The Heart) be accepted as criterion for death. The report sparked controversy and concern that, in their eagerness to recover organs, physicians might declare death prematurely. Over time, the concept of brain death became widely accepted and remains the foundation for most deceased organ donation today.
As transplantation became safer and more successful and more patients became eligible for life-saving procedures, the demand for donor organs quickly outpaced the available supply. Thus arose another question: how should these scarce and valuable resources be allocated fairly?
In the US, the National Organ Transplant Act of 1984 established a national framework for organ recovery and allocation. The non-profit organization United Network for Organ Sharing (UNOS), soon received the initial federal contract to operate the Organ Procurement and Transplantation Network (OPTN) – matching donors and recipients using factors such as blood type, tissue compatibility, organ size, medical urgency, location, and other clinical criteria. Marthe’s song “Strike the Match” in The Heart captures this complex process.
In 2022, the US performed its one millionth organ transplant — a milestone that came from a century of innovation and scientific progress and countless acts of generosity. As we see in The Heart, each transplant requires extraordinary cooperation among physicians, nurses, emergency personnel, organ procurement specialists, donors, and of course, the grieving families who cooperate to give the gift of life, one person at a time.